Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Schwarzenböck

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 27, 2012
FDG PET and PET/CTBerud J Krause, Sarah Schwarzenböck, Michael Souvatzoglou
Diagnostics (Basel, Switzerland)|February 25, 2022
Negative Venous Leg Ultrasound in Acute Pulmonary Embolism: Prevalence, Clinical Characteristics and PredictorsMattes Becher, Thomas Heller, Sarah Schwarzenböck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2025
First-in-Human Serum Stability Studies of [<sup>177</sup>Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical TherapyVeronika Felber, Nadine Holzleitner, Markus Joksch, et al.
Plos One|October 1, 2014
CT-based attenuation correction in I-123-ioflupane SPECTCatharina Lange, Anita Seese, Sarah Schwarzenböck, et al.
European Radiology|February 27, 2015
Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphyCatharina Lange, Jens Kurth, Anita Seese, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2023
Preclinical Comparison of the <sup>64</sup>Cu- and <sup>68</sup>Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [<sup>68</sup>Ga]Ga-AMTG PET/CTLena Koller, Markus Joksch, Sarah Schwarzenböck, et al.
Plos One|May 8, 2014
Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalinsReinhard Meier, Rickmer Braren, Yvonne Kosanke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 3, 2025
PET imaging utilization and trends in Germany: a comprehensive surveyAdrien Holzgreve, Dirk Hellwig, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective StudyWolfgang Peter Fendler, Jeremie Calais, Martin Allen-Auerbach, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 27, 2012
FDG PET and PET/CTBerud J Krause, Sarah Schwarzenböck, Michael Souvatzoglou
Diagnostics (Basel, Switzerland)|February 25, 2022
Negative Venous Leg Ultrasound in Acute Pulmonary Embolism: Prevalence, Clinical Characteristics and PredictorsMattes Becher, Thomas Heller, Sarah Schwarzenböck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2025
First-in-Human Serum Stability Studies of [<sup>177</sup>Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical TherapyVeronika Felber, Nadine Holzleitner, Markus Joksch, et al.
Plos One|October 1, 2014
CT-based attenuation correction in I-123-ioflupane SPECTCatharina Lange, Anita Seese, Sarah Schwarzenböck, et al.
European Radiology|February 27, 2015
Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphyCatharina Lange, Jens Kurth, Anita Seese, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2023
Preclinical Comparison of the <sup>64</sup>Cu- and <sup>68</sup>Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [<sup>68</sup>Ga]Ga-AMTG PET/CTLena Koller, Markus Joksch, Sarah Schwarzenböck, et al.
Plos One|May 8, 2014
Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalinsReinhard Meier, Rickmer Braren, Yvonne Kosanke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 3, 2025
PET imaging utilization and trends in Germany: a comprehensive surveyAdrien Holzgreve, Dirk Hellwig, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective StudyWolfgang Peter Fendler, Jeremie Calais, Martin Allen-Auerbach, et al.
Pageof 1